1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow ABSK141-400mg: new trials by email Literature Review of ABSK141-400mg trials Research Report on ABSK141-400mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 ) ABSK141-400mg, ABSK141-Recommended Dose for Expansion (RDE), ABSK141-800mg - Solid Tumors, Adult | Phase 1 / Phase 2 | Recruiting | Abbisko Therapeutics Co, Ltd | 401 | 2026-03-02 | 2026-03-11 |
Abbisko Therapeutics Co, Ltd (1)
China (1)